Published in HIV Med on March 01, 2006
Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial. Ann Intern Med (2010) 1.71
Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. J Gen Intern Med (2009) 1.63
A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine. Antivir Ther (2012) 1.48
Cardiovascular complications in HIV management: past, present, and future. J Acquir Immune Defic Syndr (2009) 1.20
Recruitment and retention of diverse populations in antiretroviral clinical trials: practical applications from the gender, race and clinical experience study. J Womens Health (Larchmt) (2011) 1.15
The lipid profile of HIV-infected patients receiving antiretroviral therapy in a rural Cameroonian population. BMC Public Health (2014) 1.08
Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study. J Antimicrob Chemother (2010) 0.96
Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution. Int J Vasc Med (2011) 0.95
Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials. AIDS (2015) 0.91
HAART-associated dyslipidemia varies by biogeographical ancestry in the multicenter AIDS cohort study. AIDS Res Hum Retroviruses (2013) 0.87
Lipid management in patients who have HIV and are receiving HIV therapy. Endocrinol Metab Clin North Am (2009) 0.86
Management of dyslipidemia in HIV-infected patients. Clin Lipidol (2011) 0.83
Sex differences in responses to antiretroviral treatment in South African HIV-infected children on ritonavir-boosted lopinavir- and nevirapine-based treatment. BMC Pediatr (2014) 0.82
Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks. AIDS Patient Care STDS (2011) 0.82
Nucleoside reverse transcriptase inhibitors in combination therapy for HIV patients: systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis (2010) 0.81
Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution. HIV Med (2009) 0.80
Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV. Adv Ther (2010) 0.80
Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon. BMC Cardiovasc Disord (2015) 0.78
Use of nucleoside reverse transcriptase inhibitor-only regimens in HIV-infected children and adolescents. Pediatr Infect Dis J (2013) 0.76
Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results. BMC Infect Dis (2013) 0.76
Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats. PLoS One (2015) 0.76
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. N Engl J Med (1999) 7.28
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA (1997) 6.35
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA (1996) 5.29
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA (1998) 4.61
CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science (1991) 4.53
Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock. Science (1993) 3.03
Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N Engl J Med (1990) 2.80
Phase variation in tcpH modulates expression of the ToxR regulon in Vibrio cholerae. Mol Microbiol (1997) 2.71
Clinical pharmacokinetics of lamivudine. Clin Pharmacokinet (1999) 2.40
Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell (2001) 2.29
Comparison of a hemagglutination treponemal test for syphilis (HATTS) with other serologic methods for the diagnosis of syphilis. Sex Transm Dis (1979) 2.14
A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial. J Am Coll Cardiol (1999) 2.14
Rec8p, a meiotic recombination and sister chromatid cohesion phosphoprotein of the Rad21p family conserved from fission yeast to humans. Mol Cell Biol (1999) 2.09
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol (1996) 2.07
False-positive reactions in the rapid plasma reagin-card, fluorescent treponemal antibody-absorbed, and hemagglutination treponemal syphilis serology tests. J Clin Microbiol (1979) 2.01
Lithographically patterned nanowire electrodeposition. Nat Mater (2006) 1.86
The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1. AIDS (1999) 1.78
Epidemiology of an international outbreak of Salmonella agona. Lancet (1973) 1.76
Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS (2001) 1.68
Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs (1980) 1.67
Fos family members induce cell cycle entry by activating cyclin D1. Mol Cell Biol (1998) 1.61
Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs (1980) 1.59
Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. Ann Intern Med (1997) 1.58
Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs (1981) 1.55
Differential corticospinal tract degeneration in homozygous 'D90A' SOD-1 ALS and sporadic ALS. J Neurol Neurosurg Psychiatry (2011) 1.55
Nefopam: a review of its pharmacological properties and therapeutic efficacy. Drugs (1980) 1.51
Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer. Oncogene (1999) 1.47
Plague in San Diego. West J Med (1978) 1.45
Diagnosis of acute HIV infection: it's time to get moving! Ann Intern Med (2001) 1.45
Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections. Drugs (1980) 1.43
Drug-induced hypertrichosis: case report and review of the literature. DICP (1990) 1.39
Activating transcription factor-1 can mediate Ca(2+)- and cAMP-inducible transcriptional activation. J Biol Chem (1993) 1.39
Inhibition of norfloxacin absorption by antacids. Antimicrob Agents Chemother (1990) 1.38
Pharmacologic strategies for treating gastroesophageal reflux disease. Clin Ther (2000) 1.38
Pharmacokinetics of tacrolimus in liver transplant patients. Clin Pharmacol Ther (1995) 1.33
Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma. Am Rev Respir Dis (1992) 1.33
The detection of a population of submillimeter-bright, strongly lensed galaxies. Science (2010) 1.28
Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg (1991) 1.27
Adenovirus type 7b in a children's hospital. J Infect Dis (1983) 1.26
Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials. Antimicrob Agents Chemother (1999) 1.25
The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1. Eur J Pharmacol (1993) 1.21
Nucleotide sequence comparison of the Adh gene in three drosophilids. J Mol Evol (1984) 1.18
Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART). J Acquir Immune Defic Syndr (1999) 1.17
Pharmacokinetics of zidovudine and lamivudine in neonates following coadministration of oral doses every 12 hours. J Clin Pharmacol (2001) 1.17
Epidemiology of cervical cancer by cell type. Cancer Res (1987) 1.17
Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg (1989) 1.10
Induction and maintenance of increased VEGF protein by chronic motor nerve stimulation in skeletal muscle. Am J Physiol (1998) 1.07
Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J Neurochem (1992) 1.06
Lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with lamivudine and zidovudine administered concurrently and the effect of food on absorption. J Clin Pharmacol (1999) 1.06
Development of a feline whole genome radiation hybrid panel and comparative mapping of human chromosome 12 and 22 loci. Genomics (1999) 1.06
The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur Respir J (1993) 1.03
Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine. AIDS (2000) 1.03
Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein. Oncogene (2006) 1.01
Characterization of variable-region genes and shared crossreactive idiotypes of antibodies specific for antigens of various influenza viruses. Viral Immunol (1987) 1.01
Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa. Cell Growth Differ (1992) 0.99
Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome. Adv Ther (2001) 0.97
Antineoplastic agents 320: synthesis of a practical pancratistatin prodrug. Anticancer Drug Des (1995) 0.97
What liver transplant outcomes can be expected in the uninsured who become insured via the Affordable Care Act? Am J Transplant (2013) 0.96
Gender and acute myocardial infarction: is there a different response to thrombolysis? J Am Coll Cardiol (1997) 0.96
cDNA and deduced protein sequence for the beta B1-crystallin polypeptide of the chicken lens. Conservation of the PAPA sequence. J Biol Chem (1986) 0.92
Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses. Cephalalgia (1997) 0.92
The E1a gene of adenovirus type 2 reduces the metastatic potential of ras-transformed rat embryo cells. Mol Cell Biol (1988) 0.92
Calcium regulation of immediate early gene transcription. J Physiol Paris (1992) 0.92
DF-2 bacteremia following a dog bite in a 4-month-old child. Pediatr Infect Dis J (1987) 0.91
Comparative gene mapping in the domestic cat (Felis catus). J Hered (1997) 0.91
NF1-L is the DNA-binding component of the protein complex at the peripherin negative regulatory element. J Biol Chem (1995) 0.90
A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy. Arch Surg (1992) 0.90
Nicotinic acid-adenine dinucleotide phosphate (NAADP) elicits specific microsomal Ca2+ release from mammalian cells. Biochem J (2001) 0.89
Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. AIDS (2000) 0.89
Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma. J Allergy Clin Immunol (1992) 0.88
Cytoreduction of ovarian cancer with the Cavitron ultrasonic surgical aspirator. Obstet Gynecol (1988) 0.88
Cooperation between Shh and IGF-I in promoting myogenic proliferation and differentiation via the MAPK/ERK and PI3K/Akt pathways requires Smo activity. J Cell Physiol (2012) 0.88
Restricted adult clonal profiles induced by neonatal immunization. Influence of suppressor T cells. J Exp Med (1983) 0.87
A comparison of international learning experiences for baccalaureate nursing students: developed and developing countries. J Nurs Educ (1998) 0.87
Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa. J Am Acad Dermatol (1990) 0.87
Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patients. NV15355 Study Team. AIDS (1998) 0.87
Assessment of MK-912, an alpha 2-adrenoceptor antagonist, with use of intravenous clonidine. Clin Pharmacol Ther (1989) 0.87
Altered cortical activation during a motor task in ALS. Evidence for involvement of central pathways. J Neurol (2007) 0.87
Ecology of Borrelia burgdorferi in ticks (Acari: Ixodidae), rodents, and birds in the Sierra Nevada foothills, Placer County, California. J Med Entomol (2000) 0.86
Successful application of extracorporeal liver perfusion: a technology whose time has come. Am J Gastroenterol (1993) 0.86
Nicotinic acid adenine dinucleotide phosphate: a new Ca2+ releasing agent in kidney. J Am Soc Nephrol (2001) 0.85
Neurologic complications of nonneuronopathic Gaucher's disease. Arch Neurol (1991) 0.85
Conservation of coding and transcriptional control sequences within the snRNP E protein gene. Genomics (1992) 0.85
Colonic expression of c-myb is initiated in utero and continues throughout adult life. Cell Growth Differ (1996) 0.85
Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. Drugs (1980) 0.85
Activity of the distal positive element of the peripherin gene is dependent on proteins binding to an Ets-like recognition site and a novel inverted repeat site. J Biol Chem (1996) 0.84
cADP-ribose/ryanodine channel/Ca2+-release signal transduction pathway in mesangial cells. Am J Physiol Renal Physiol (2001) 0.84
Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virus type 1: results of the TARGET Study. J Infect Dis (2001) 0.83
Leukotriene (LT) D4 is involved in antigen-induced asthma: a study with the LTD4 receptor antagonist, MK-571. Ann N Y Acad Sci (1991) 0.83
Fungal disease in liver transplant recipients: a multivariate analysis of risk factors. Transplant Proc (1991) 0.82
Arterial pressure and pulse interval responses to repetitive carotid baroreceptor stimuli in man. J Physiol (1979) 0.82
Cyclic ADP-ribose signaling in sea urchin gametes: metabolism in spermatozoa. Am J Physiol (1997) 0.82
Diflunisal: a review of its pharmacological properties and therapeutic use in pain and musculoskeletal strains and sprains and pain in osteoarthritis. Drugs (1980) 0.81
Indinavir nephropathy. N Engl J Med (1997) 0.81